NCT05756179View on ClinicalTrials.gov

Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Diosmin and Hesperidin Combination

Diosmin 450 mg and Hesperidin 50 mg Combination

Trial Locations (1)

Unknown

RECRUITING

Alexandria university hospital, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER